COMPARATIVE PHARMACODYNAMICS AND PHARMACOKINETICS OF CONVENTIONAL AND LONG-ACTING PROPRANOLOL

被引:0
|
作者
TAKAHASHI, H
OGATA, H
KANNO, S
KASHIWADA, K
OHIRA, M
SOMEYA, K
机构
[1] MEIJI COLL PHARM,TOKYO 154,JAPAN
[2] ST MARIANNA UNIV,KAWASAKI,KANAGAWA 213,JAPAN
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:S119 / S119
页数:1
相关论文
共 50 条
  • [21] CONVENTIONAL PROPRANOLOL (INDERAL) VERSUS LONG-ACTING PROPRANOLOL (INDERAL LA) IN ANGINA-PECTORIS
    LEENEN, FHH
    VANDERVIJGH, AB
    CLINICAL RESEARCH, 1980, 28 (03): : A664 - A664
  • [22] Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor
    Dario Cattaneo
    Cristina Gervasoni
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 319 - 327
  • [23] Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor
    Cattaneo, Dario
    Gervasoni, Cristina
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2019, 44 (03) : 319 - 327
  • [24] Comparisons of the effects of different long-acting delivery systems on the pharmacokinetics and pharmacodynamics of diltiazem
    Smith, DHG
    Neutel, JM
    Weber, MA
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (10) : 1030 - 1037
  • [25] LONG-ACTING PROPRANOLOL IN ESSENTIAL TREMOR
    KOLLER, W
    ANNALS OF NEUROLOGY, 1984, 16 (01) : 125 - 125
  • [26] LONG-ACTING PROPRANOLOL IN ESSENTIAL TREMOR
    KOLLER, WC
    NEUROLOGY, 1985, 35 (01) : 108 - 110
  • [27] LONG-ACTING PROPRANOLOL IN MIGRAINE PROPHYLAXIS
    HAVANKAKANNIAINEN, H
    HOKKANEN, E
    MYLLYLA, VV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (02) : 203 - 203
  • [28] LONG-ACTING PROPRANOLOL IN THE PROPHYLAXIS OF MIGRAINE
    DIAMOND, S
    SOLOMON, GD
    FREITAG, FG
    MEHTA, ND
    HEADACHE, 1987, 27 (02): : 70 - 72
  • [29] THE BIOAVAILABILITY OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL - A COMPARISON OF CONVENTIONAL AND LONG-ACTING PREPARATIONS
    RAVENSCROFT, PJ
    CHARLES, BG
    RENSHAW, PJ
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1982, 9 (04) : 459 - 459
  • [30] COMPARISON OF LONG-ACTING AND CONVENTIONAL PROPRANOLOL GIVEN ONCE DAILY IN MODERATE HYPERTENSION
    VANDONGEN, R
    BEILIN, LJ
    LALOR, C
    WALL, BP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1983, 10 (02) : 190 - 190